Cardio Diagnostics Holdings (NASDAQ: CDIO), an AI-driven precision cardiovascular medicine company, has released an updated edition of its “State of Rural Hospitals and Cardiovascular Care” report. The report is designed to assist rural healthcare leaders, policymakers, and community-based organizations in improving cardiovascular care quality and outcomes. It addresses critical challenges such as specialist and physician shortages, limited broadband access, and the higher cardiovascular disease risk among rural populations.
The revised report presents an updated four-part care model focused on upskilling primary care clinicians, advancing care through epigenetic-genetic testing, implementing population-wide health strategies, and integrating remote care options in rural communities. Cardio Diagnostics stated that the report also examines the role of technologies like virtual cardiac care and precision-medicine testing in strengthening early detection, access, and personalized care.
Cardio Diagnostics is an artificial intelligence-powered precision cardiovascular medicine company that aims to make cardiovascular disease prevention, detection, and management more accessible, personalized, and precise. The company leverages a proprietary AI-driven Integrated Genetic-Epigenetic Engine to develop and commercialize clinical tests for cardiovascular disease.
The latest news and updates relating to CDIO are available in the company’s newsroom at https://ibn.fm/CDIO.
